MediXall (MDXL) Shares Outstanding (2019 - 2024)
MediXall's Shares Outstanding history spans 8 years, with the latest figure at $168.9 million for Q3 2024.
- For Q3 2024, Shares Outstanding rose 4219.51% year-over-year to $168.9 million; the TTM value through Sep 2024 reached $168.9 million, up 4219.51%, while the annual FY2023 figure was $130.5 million, 6.8% up from the prior year.
- Shares Outstanding reached $168.9 million in Q3 2024 per MDXL's latest filing, up from $88298.0 in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $168.9 million in Q3 2024 to a low of $88298.0 in Q2 2024.
- Average Shares Outstanding over 5 years is $75.7 million, with a median of $105.4 million recorded in 2021.
- Peak YoY movement for Shares Outstanding: crashed 99.77% in 2023, then skyrocketed 52197.77% in 2024.
- A 5-year view of Shares Outstanding shows it stood at $98.9 million in 2020, then grew by 12.1% to $110.9 million in 2021, then increased by 10.21% to $122.2 million in 2022, then grew by 6.8% to $130.5 million in 2023, then rose by 29.41% to $168.9 million in 2024.
- Per Business Quant, the three most recent readings for MDXL's Shares Outstanding are $168.9 million (Q3 2024), $138.9 million (Q2 2024), and $138.5 million (Q1 2024).